Telegraft Editorial Board


The Telegraft is the leading global cell therapy newsletter. It is provided as a benefit of ISCT membership online. It is also used as a promotional vehicle for ISCT activities. This bi-monthly e-newsletter includes insightful discussions and up-to-date information on critical issues affecting the field of cellular therapy.

The Telegraft provides those in or interested in the cell therapy community with current information on new developments, items of interest, regulatory updates, and regular columns on related meetings, organizations and events, summaries of work being done in both academic and industry labs around the world, and much more. Special issues are also published as required to cover developments of particular importance or interest to the membership. 

For the 2022 Telegraft Submission Deadline and Release Schedule, as well as for information on how to submit articles and article suggestions to Telegraft , please view below:

Editorial Board

Headshot of Janet Macpherson

Senior Editor

Janet Macpherson, PhD

Sydney, Australia

Headshot of Russell Cruz

Senior Editor

Russell Cruz, MD

Children's National Medical Center
Washington, DC, United States

Junior Associate Editors

Rounak Dubey, MBBS, MD
All India Institute of Medical Sciences
Raipur, India

Contributing Editors

Shyam Bhakta, MD, MBA, FACC, FAHA, FSCAI
Case Western Reserve University National Center for Regenerative Medicine
Cleveland, United States

Ashely Krull, BSc, PhD
Mayo Clinic Rochester
Rochester, United States

Wouter Van't Hof, PhD
Cleveland Cord Blood Center
Cleveland, United States

Joaquim Vives, PhD
Banc De Sang I Teixits
Barcelona, Spain